BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shao X, Uojima H, Setsu T, Okubo T, Atsukawa M, Furuichi Y, Arase Y, Hidaka H, Tanaka Y, Nakazawa T, Kako M, Kagawa T, Iwakiri K, Terai S, Koizumi W. Usefulness of autotaxin for the complications of liver cirrhosis. World J Gastroenterol 2020; 26(1): 97-108 [PMID: 31933517 DOI: 10.3748/wjg.v26.i1.97] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Saleh SAB, Abdelwahab KM, Mady AM, Mohamed GA. The impact of achieving a sustained virological response with direct-acting antivirals on serum autotaxin levels in chronic hepatitis C patients. Egypt Liver Journal 2020;10. [DOI: 10.1186/s43066-020-00060-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Flores-López M, García-Marchena N, Pavon FJ, Lara E, Porras-Perales O, Araos P, Requena-Ocaña N, Torres-Galván S, Mañas-Padilla MC, Rubio G, Suárez J, Santín LJ, Rodríguez de Fonseca F, Castilla-Ortega E, García-Fernández MI, Serrano A. Plasma Concentrations of Lysophosphatidic Acid and Autotaxin in Abstinent Patients with Alcohol Use Disorder and Comorbid Liver Disease. Biomedicines 2021;9:1207. [PMID: 34572393 DOI: 10.3390/biomedicines9091207] [Reference Citation Analysis]
3 Trovato FM, Zia R, Napoli S, Wolfer K, Huang X, Morgan PE, Husbyn H, Elgosbi M, Lucangeli M, Miquel R, Wilson I, Heaton ND, Heneghan MA, Auzinger G, Antoniades CG, Wendon JA, Patel VC, Coen M, Triantafyllou E, McPhail MJ. Dysregulation of the Lysophosphatidylcholine/Autotaxin/Lysophosphatidic Acid Axis in Acute-on-Chronic Liver Failure Is Associated With Mortality and Systemic Inflammation by Lysophosphatidic Acid-Dependent Monocyte Activation. Hepatology 2021;74:907-25. [PMID: 33908067 DOI: 10.1002/hep.31738] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]